These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33707790)

  • 61. Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis.
    Sulli A; Ruaro B; Smith V; Paolino S; Pizzorni C; Pesce G; Cutolo M
    Arthritis Res Ther; 2017 Mar; 19(1):61. PubMed ID: 28320447
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
    Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
    Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The first composite score predicting Digital Ulcers in systemic sclerosis patients using Clinical data, Imaging and Patient history-CIP-DUS.
    Friedrich S; Lüders S; Klotsche J; Burmester GR; Riemekasten G; Ohrndorf S
    Arthritis Res Ther; 2020 Jun; 22(1):144. PubMed ID: 32539806
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis.
    Akesson A; Hesselstrand R; Scheja A; Wildt M
    Ann Rheum Dis; 2004 Jul; 63(7):791-6. PubMed ID: 15194573
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.
    Karalilova R; Kazakova M; Sapundzhieva T; Dichev V; Batalov Z; Sarafian V; Batalov A
    Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis.
    Bourji K; Meyer A; Chatelus E; Pincemail J; Pigatto E; Defraigne JO; Singh F; Charlier C; Geny B; Gottenberg JE; Punzi L; Cozzi F; Sibilia J
    Free Radic Biol Med; 2015 Oct; 87():282-9. PubMed ID: 26143738
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.
    Matsuda KM; Yoshizaki A; Kuzumi A; Fukasawa T; Ebata S; Miura S; Toyama T; Yoshizaki A; Sumida H; Asano Y; Oba K; Sato S
    Arthritis Res Ther; 2019 May; 21(1):129. PubMed ID: 31138286
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pulmonary Manifestations in Systemic Sclerosis: Hospital-Based Descriptive Study.
    Mulkoju R; Saka VK; Rajaram M; Kumari R; Negi VS; Mohanty Mohapatra M; Govindaraj V; Dwivedi DP; Mahesh Babu V
    Cureus; 2020 Jun; 12(6):e8649. PubMed ID: 32685316
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Durometry for the assessment of skin disease in systemic sclerosis.
    Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
    Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS].
    Rimar D; Slobodin G; Rosner I; Rozenbaum M; Kaly L; Boulman N; Jiries N; Awisat A; Vadasz Z
    Harefuah; 2017 Jul; 156(7):418-421. PubMed ID: 28786275
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study.
    Nacci F; Righi A; Conforti ML; Miniati I; Fiori G; Martinovic D; Melchiorre D; Sapir T; Blank M; Shoenfeld Y; Pignone AM; Cerinic MM
    Ann Rheum Dis; 2007 Jul; 66(7):977-9. PubMed ID: 17344244
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dysregulation of angiogenic homeostasis in systemic sclerosis.
    Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
    Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.
    Terras S; Hartenstein H; Höxtermann S; Gambichler T; Kreuter A
    Int J Dermatol; 2016 Aug; 55(8):882-5. PubMed ID: 26499848
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.
    Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Muro Y; Ogawa F; Sasaki T; Takahashi H; Tanaka S; Takehara K; Sato S
    Rheumatology (Oxford); 2012 Jan; 51(1):129-33. PubMed ID: 22072085
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: Analysis of a cohort of 239 patients.
    Leroy V; Henrot P; Barnetche T; Cario M; Darrigade AS; Manicki P; Doutre MS; Lazaro E; Constans J; Barcat D; Vernhes JP; Richez C; Taieb A; Truchetet ME; Seneschal J;
    J Am Acad Dermatol; 2019 Feb; 80(2):478-484. PubMed ID: 30092330
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience.
    Castellví I; Elhai M; Bruni C; Airò P; Jordan S; Beretta L; Codullo V; Montecucco CM; Bokarewa M; Iannonne F; Balbir A; Hsu VM; Distler O; Matucci-Cerinic M; Allanore Y;
    Semin Arthritis Rheum; 2020 Dec; 50(6):1489-1493. PubMed ID: 32165035
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A novel approach to measuring skin elasticity in systemic sclerosis: results from a pilot study.
    Galarraga B; McSwiggan S; Caswell FR; Brodie RC; Sharma P; Abel EW; Newton DJ; Belch JJ
    Scand J Rheumatol; 2011 May; 40(3):211-6. PubMed ID: 21231806
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis.
    Kilic G; Kilic E; Akgul O; Ozgocmen S
    Int J Rheum Dis; 2016 Apr; 19(4):405-11. PubMed ID: 24283757
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systemic sclerosis (scleroderma): remaining challenges.
    Connolly MK
    Ann Transl Med; 2021 Mar; 9(5):438. PubMed ID: 33842659
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ultrasound in the assessment of musculoskeletal involvement in systemic sclerosis.
    Iagnocco A; Ceccarelli F; Vavala C; Gattamelata A; Scirocco C; Rutigliano IM; Valesini G
    Med Ultrason; 2012 Sep; 14(3):231-4. PubMed ID: 22957329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.